ArticleEuropean journal of medical research2024

Nafamostat mesylate versus regional citrate anticoagulation for continuous renal replacement therapy in patients at high risk of bleeding: a retrospective single-center study.

Dan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.